Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.250
+0.020 (1.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.290
+0.040 (3.20%)
Pre-market: Mar 10, 2026, 6:30 AM EDT
Immunic Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 163 | 64 | 90 | 68 | 62 | 251 | |
| Market Cap Growth | 42.55% | -28.73% | 33.02% | 9.04% | -75.28% | -20.70% | |
| Enterprise Value | 148 | 30 | 32 | 9 | -10 | 142 | |
| Last Close Price | 1.25 | 0.53 | 1.00 | 1.50 | 1.40 | 9.57 | |
| PB Ratio | - | -9.62 | 4.89 | 2.34 | 0.55 | 1.98 | |
| P/TBV Ratio | - | - | 4.89 | 2.34 | 0.55 | 2.67 | |
| Debt / Equity Ratio | -0.09 | -0.09 | 0.05 | 0.05 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | 2.23 | 2.23 | -1.88 | -1.57 | -1.01 | -0.68 | |
| Net Debt / EBITDA Ratio | 0.14 | 0.14 | 0.35 | 0.46 | 1.33 | 1.16 | |
| Net Debt / FCF Ratio | 0.17 | 0.17 | 0.41 | 0.64 | 1.76 | 1.03 | |
| Quick Ratio | 0.64 | 0.64 | 1.64 | 1.99 | 9.10 | 7.81 | |
| Current Ratio | 0.75 | 0.75 | 1.77 | 2.12 | 9.63 | 9.21 | |
| Return on Equity (ROE) | -1653.15% | -1653.15% | -424.44% | -131.28% | -100.01% | -65.02% | |
| Return on Assets (ROA) | -198.76% | -198.76% | -128.79% | -68.13% | -40.53% | -30.30% | |
| Return on Capital Employed (ROCE) | 1572.20% | 1572.20% | -524.50% | -335.60% | -75.40% | -58.30% | |
| Earnings Yield | -59.59% | -151.37% | -111.58% | -138.24% | -193.89% | -37.00% | |
| FCF Yield | -52.71% | -133.91% | -94.39% | -105.09% | -105.08% | -33.16% | |
| Buyback Yield / Dilution | -55.42% | -55.42% | -126.03% | -39.29% | -34.52% | -51.00% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.